NEW YORK--(BUSINESS WIRE)--March 30, 2004--The annual Rodman & Renshaw Techvest Global Healthcare Conference will be held at Claridge’s Hotel in London, 12-14 May 2004.
Over 150 emerging growth biotechnology companies are scheduled to present their product pipelines. The companies represent the cutting edge of science in the fields of oncology, cardiovascular disease, central nervous system disorders, infectious diseases, autoimmune diseases, drug delivery, gene therapy, specialty pharmaceuticals, therapeutic vaccines, and medical devices.
Over the three-day conference, each company will host a twenty-minute presentation followed by a breakout session and opportunities for one-on-one meetings.
On Wednesday evening, May 12th, all registered attendees are also invited to a gala event hosted by Rodman & Renshaw: a cocktail cruise on the River Thames headed to the National Maritime Museum in Greenwich, home of the Greenwich Mean Time Observatory, for dinner and entertainment.
On Thursday, May 13th, a dinner will be hosted by Rodman & Renshaw at Kensington Palace.
Conference attendance is offered free to institutional investors, venture capitalists and related pharmaceutical industry management and scientific officers.
Interested attendees can register on-line free of charge at www.rodmanandrenshaw.com or by calling Lily Khaykina in the US at 212.356.0529.
Supporting sponsors of the event include: The Investor Relations Group, Business Wire, Battelle Health and Life Sciences, Bioventure View, Vintage Filings, Biocommerce Data, and D&MD Publications.
For more information contact: The Investor Relations Group Inc. 212.825.3210.
Contacts
Rodman & Renshaw Lily Khaykina, 212-356-0529 or The Investor Relations Group Inc. Dian Griesel, 212-825-3210
